Cosmo Bio Co

Cosmo Bio Co Market capitalization

The The market capitalization of Cosmo Bio Co (3386.T) as of Oct 27, 2026 is 7.75 B JPY. In the previous year, The market capitalization was 7.75 B JPY — a change of 0.00% (lower).

Market capitalization

7.75 BJPY

YoY

0.00%

Last updated:

In 2025, Cosmo Bio Co's market cap stood at 7.75 B JPY, a 0.00% increase from the 7.75 B JPY market cap in the previous year.

The Cosmo Bio Co Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
7.75 B JPY
Jan 1, 2019
7.75 B JPY
Jan 1, 2020
7.75 B JPY
Jan 1, 2021
7.75 B JPY
Jan 1, 2022
7.75 B JPY
Jan 1, 2023
7.75 B JPY
Jan 1, 2024
7.75 B JPY
Jan 1, 2025
7.75 B JPY
The Cosmo Bio Co Market capitalization history
YEARMarket capitalizationYoY
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY0.00%
7.75 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cosmo Bio Co Stock analysis

What does Cosmo Bio Co do? Cosmo Bio Co., Ltd. generates revenue through the export, import, and sale of bio-research reagents, instruments, and software, as well as clinical diagnostics. The company imports research reagents primarily from the United States and Europe, which are utilized in life science research. In the equipment segment, Cosmo Bio handles specialized life science research equipment sourced from domestic and overseas suppliers, targeting domestic market sales. The equipment includes ultrasonic cell disruption devices, bioimaging systems, and research consumables. Clinical test drugs are sold mainly to hospitals and testing centers. The company's research reagents business focuses on importing products from the United States and Europe, which are prioritized for life science research applications. Equipment sales target domestic customers seeking specialized life science research tools, including ultrasonic cell disruption equipment and bioimaging-related devices. Clinical diagnostics products are distributed to hospitals and testing centers for medical testing purposes. Cosmo Bio's revenue streams are divided into three main segments: bio-research reagents, life science equipment, and clinical diagnostics. The reagents segment relies on imports from the United States and Europe, while the equipment segment features products like ultrasonic cell disruption equipment and bioimaging systems. Clinical diagnostics products are sold to hospitals and testing centers as test drugs for medical use. Cosmo Bio Co is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Cosmo Bio Co's Market Capitalization

Cosmo Bio Co's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Cosmo Bio Co's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Cosmo Bio Co's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Cosmo Bio Co’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Cosmo Bio Co stock

The market capitalization of Cosmo Bio Co is 7.75 B JPY in 2025.

The market capitalization of Cosmo Bio Co changed from 7.75 B JPY to 7.75 B JPY, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Cosmo Bio Co since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's JPY, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' JPY varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Cosmo Bio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cosmo Bio Co

All Key Metrics — Cosmo Bio Co